Literature DB >> 1514459

Inappropriate medication is a major cause of adverse drug reactions in elderly patients.

C M Lindley1, M P Tully, V Paramsothy, R C Tallis.   

Abstract

To determine the extent to which adverse drug reactions (ADRs) in elderly patients admitted to hospital are due to inappropriate prescribing, we examined 416 successive admissions of elderly patients to a teaching hospital. Interacting drug combinations and drugs with relative contra-indications (CIs) were common, but not as important in producing ADRs as drugs with absolute CIs or unnecessary drugs. Forty-eight patients (11.5% of admissions) were taking a total of 51 drugs with absolute CIs (3.8% of prescriptions). One hundred and seventy-five drugs were discontinued on or shortly after admission in 113 (27%) patients because they were deemed to be unnecessary. One hundred and three patients (27.0% of those on medication) experienced 151 ADRs of which 75 (49.7%) were due to drugs with absolute CIs and/or that were unnecessary, a significantly higher rate of ADRs (p less than 0.001) than observed for all prescriptions. Of 26 (6.3%) admissions attributed to ADRs, 13 (50%) were due to inappropriate prescriptions. The admission rate per prescription was significantly higher (p less than 0.001) for inappropriate than for appropriate drugs. We conclude that much drug-related morbidity in the elderly population may be avoidable, as it is due to inappropriate prescribing.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1514459     DOI: 10.1093/ageing/21.4.294

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  82 in total

1.  Hospital prescribing errors: epidemiological assessment of predictors.

Authors:  R Fijn; P M L A Van den Bemt; M Chow; C J De Blaey; L T W De Jong-Van den Berg; J R B J Brouwers
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

2.  Effects of a medicine review and education programme for older people in general practice.

Authors:  C J Lowe; D K Raynor; J Purvis; A Farrin; J Hudson
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

3.  Therapy related hospital admission in patients on polypharmacy in Singapore: a pilot study.

Authors:  Yvonne Koh; Bte Moideen Kutti Fatimah; Shu Chuen Li
Journal:  Pharm World Sci       Date:  2003-08

Review 4.  Pharmaceutical care programmes for the elderly: economic issues.

Authors:  Grainne E Crealey; Ian K Sturgess; James C McElnay; Carmel M Hughes
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

5.  Adverse drug reactions in a population of hospitalized very elderly patients.

Authors:  Balamurugan Tangiisuran; J Graham Davies; Juliet E Wright; Chakravarthi Rajkumar
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

6.  Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.

Authors:  Roberto Leone; Lara Magro; Ugo Moretti; Paola Cutroneo; Martina Moschini; Domenico Motola; Marco Tuccori; Anita Conforti
Journal:  Drug Saf       Date:  2010-08-01       Impact factor: 5.606

Review 7.  Comparison of published explicit criteria for potentially inappropriate medications in older adults.

Authors:  Chirn-Bin Chang; Ding-Cheng Chan
Journal:  Drugs Aging       Date:  2010-12-01       Impact factor: 3.923

Review 8.  Adverse drug reactions in older people: detection and prevention.

Authors:  Mirko Petrovic; Tischa van der Cammen; Graziano Onder
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

9.  Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.

Authors:  D B Hogan; N R Campbell; R Crutcher; P Jennett; N MacLeod
Journal:  CMAJ       Date:  1994-08-01       Impact factor: 8.262

Review 10.  Drug-related problems in hospitals: a review of the recent literature.

Authors:  Anita Krähenbühl-Melcher; Raymond Schlienger; Markus Lampert; Manuel Haschke; Jürgen Drewe; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.